Click for best price
Prostate Cancer Therapeutics Drugs Market Size, Share 2024
The Global Prostate Cancer Treatment Device market was valued at US$ 4,500 million in 2023 and is projected to reach US$ 7,875.625 million by 2030, at a CAGR of 7.50% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The USA market for Global Prostate Cancer Therapeutics Drugs market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Prostate Cancer Therapeutics Drugs market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Prostate Cancer Therapeutics Drugs market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
This report aims to provide a comprehensive presentation of the global market for Prostate Cancer Therapeutics Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer Therapeutics Drugs. This report contains market size and forecasts of Prostate Cancer Therapeutics Drugs in global, including the following market information:
- Global Prostate Cancer Therapeutics Drugs Market Revenue, 2019-2024, 2024-2030, ($ millions)
- Global Prostate Cancer Therapeutics Drugs Market Sales, 2019-2024, 2024-2030, (K Pcs)
- Global top five Prostate Cancer Therapeutics Drugs companies in 2023 (%)
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Hormone Therapy Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Prostate Cancer Therapeutics Drugs include Johnson & Johnson, Pfizer, Inc, AstraZeneca, Amgen, Inc, AbbVie, Inc, Bayer AG, Ipsen Group, Sanofi and Endo Pharmaceuticals, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Prostate Cancer Therapeutics Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prostate Cancer Therapeutics Drugs Market, by Type, 2019-2024, 2024-2030 ($ Millions) & (K Pcs)
Global Prostate Cancer Therapeutics Drugs Market Segment Percentages, by Type, 2023 (%)
- Hormone Therapy
- Chemotherapy
- Biologic Therapy
- Targeted Therapy
- Other
Global Prostate Cancer Therapeutics Drugs Market, by Sale Channel, 2019-2024, 2024-2030 ($ Millions) & (K Pcs)
Global Prostate Cancer Therapeutics Drugs Market Segment Percentages, by Sale Channel, 2023 (%)
- Hospital Pharmacy
- Retail Pharmacy
- Online Sales
- Other
Global Prostate Cancer Therapeutics Drugs Market, By Region and Country, 2019-2024, 2024-2030 ($ Millions) & (K Pcs)
Global Prostate Cancer Therapeutics Drugs Market Segment Percentages, By Region and Country, 2023 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Prostate Cancer Therapeutics Drugs revenues in global market, 2019-2024 (Estimated), ($ millions)
- Key companies Prostate Cancer Therapeutics Drugs revenues share in global market, 2023 (%)
- Key companies Prostate Cancer Therapeutics Drugs sales in global market, 2019-2024 (Estimated), (K Pcs)
- Key companies Prostate Cancer Therapeutics Drugs sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Johnson & Johnson
- Pfizer, Inc
- AstraZeneca
- Amgen, Inc
- AbbVie, Inc
- Bayer AG
- Ipsen Group
- Sanofi
- Endo Pharmaceuticals
- Dendreon Corporation
Outline of Major Chapters:
Chapter 1: Introduces the definition of Prostate Cancer Therapeutics Drugs, market overview.
Chapter 2: Global Prostate Cancer Therapeutics Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Prostate Cancer Therapeutics Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by sale channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Prostate Cancer Therapeutics Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Prostate Cancer Therapeutics Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Prostate Cancer Therapeutics Drugs Market, Global Outlook and Forecast 2024-2031 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
74 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Prostate Cancer Therapeutics Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Sale Channel
1.3 Global Prostate Cancer Therapeutics Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prostate Cancer Therapeutics Drugs Overall Market Size
2.1 Global Prostate Cancer Therapeutics Drugs Market Size: 2022 VS 2031
2.2 Global Prostate Cancer Therapeutics Drugs Revenue, Prospects & Forecasts: 2019-2031
2.3 Global Prostate Cancer Therapeutics Drugs Sales: 2019-2031
3 Company Landscape
3.1 Top Prostate Cancer Therapeutics Drugs Players in Global Market
3.2 Top Global Prostate Cancer Therapeutics Drugs Companies Ranked by Revenue
3.3 Global Prostate Cancer Therapeutics Drugs Revenue by Companies
3.4 Global Prostate Cancer Therapeutics Drugs Sales by Companies
3.5 Global Prostate Cancer Therapeutics Drugs Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Prostate Cancer Therapeutics Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Prostate Cancer Therapeutics Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Prostate Cancer Therapeutics Drugs Players in Global Market
3.8.1 List of Global Tier 1 Prostate Cancer Therapeutics Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Prostate Cancer Therapeutics Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Prostate Cancer Therapeutics Drugs Market Size Markets, 2022 & 2031
4.1.2 Hormone Therapy
4.1.3 Chemotherapy
4.1.4 Biologic Therapy
4.1.5 Targeted Therapy
4.1.6 Other
4.2 By Type - Global Prostate Cancer Therapeutics Drugs Revenue & Forecasts
4.2.1 By Type - Global Prostate Cancer Therapeutics Drugs Revenue, 2019-2024
4.2.2 By Type - Global Prostate Cancer Therapeutics Drugs Revenue, 2024-2031
4.2.3 By Type - Global Prostate Cancer Therapeutics Drugs Revenue Market Share, 2019-2031
4.3 By Type - Global Prostate Cancer Therapeutics Drugs Sales & Forecasts
4.3.1 By Type - Global Prostate Cancer Therapeutics Drugs Sales, 2019-2024
4.3.2 By Type - Global Prostate Cancer Therapeutics Drugs Sales, 2024-2031
4.3.3 By Type - Global Prostate Cancer Therapeutics Drugs Sales Market Share, 2019-2031
4.4 By Type - Global Prostate Cancer Therapeutics Drugs Price (Manufacturers Selling Prices), 2019-2031
5 Sights by Sale Channel
5.1 Overview
5.1.1 By Sale Channel - Global Prostate Cancer Therapeutics Drugs Market Size, 2022 & 2031
5.1.2 Hospital Pharmacy
5.1.3 Retail Pharmacy
5.1.4 Online Sales
5.1.5 Other
5.2 By Sale Channel - Global Prostate Cancer Therapeutics Drugs Revenue & Forecasts
5.2.1 By Sale Channel - Global Prostate Cancer Therapeutics Drugs Revenue, 2019-2024
5.2.2 By Sale Channel - Global Prostate Cancer Therapeutics Drugs Revenue, 2024-2031
5.2.3 By Sale Channel - Global Prostate Cancer Therapeutics Drugs Revenue Market Share, 2019-2031
5.3 By Sale Channel - Global Prostate Cancer Therapeutics Drugs Sales & Forecasts
5.3.1 By Sale Channel - Global Prostate Cancer Therapeutics Drugs Sales, 2019-2024
5.3.2 By Sale Channel - Global Prostate Cancer Therapeutics Drugs Sales, 2024-2031
5.3.3 By Sale Channel - Global Prostate Cancer Therapeutics Drugs Sales Market Share, 2019-2031
5.4 By Sale Channel - Global Prostate Cancer Therapeutics Drugs Price (Manufacturers Selling Prices), 2019-2031
6 Sights by Region
6.1 By Region - Global Prostate Cancer Therapeutics Drugs Market Size, 2022 & 2031
6.2 By Region - Global Prostate Cancer Therapeutics Drugs Revenue & Forecasts
6.2.1 By Region - Global Prostate Cancer Therapeutics Drugs Revenue, 2019-2024
6.2.2 By Region - Global Prostate Cancer Therapeutics Drugs Revenue, 2024-2031
6.2.3 By Region - Global Prostate Cancer Therapeutics Drugs Revenue Market Share, 2019-2031
6.3 By Region - Global Prostate Cancer Therapeutics Drugs Sales & Forecasts
6.3.1 By Region - Global Prostate Cancer Therapeutics Drugs Sales, 2019-2024
6.3.2 By Region - Global Prostate Cancer Therapeutics Drugs Sales, 2024-2031
6.3.3 By Region - Global Prostate Cancer Therapeutics Drugs Sales Market Share, 2019-2031
6.4 North America
6.4.1 By Country - North America Prostate Cancer Therapeutics Drugs Revenue, 2019-2031
6.4.2 By Country - North America Prostate Cancer Therapeutics Drugs Sales, 2019-2031
6.4.3 US Prostate Cancer Therapeutics Drugs Market Size, 2019-2031
6.4.4 Canada Prostate Cancer Therapeutics Drugs Market Size, 2019-2031
6.4.5 Mexico Prostate Cancer Therapeutics Drugs Market Size, 2019-2031
6.5 Europe
6.5.1 By Country - Europe Prostate Cancer Therapeutics Drugs Revenue, 2019-2031
6.5.2 By Country - Europe Prostate Cancer Therapeutics Drugs Sales, 2019-2031
6.5.3 Germany Prostate Cancer Therapeutics Drugs Market Size, 2019-2031
6.5.4 France Prostate Cancer Therapeutics Drugs Market Size, 2019-2031
6.5.5 U.K. Prostate Cancer Therapeutics Drugs Market Size, 2019-2031
6.5.6 Italy Prostate Cancer Therapeutics Drugs Market Size, 2019-2031
6.5.7 Russia Prostate Cancer Therapeutics Drugs Market Size, 2019-2031
6.5.8 Nordic Countries Prostate Cancer Therapeutics Drugs Market Size, 2019-2031
6.5.9 Benelux Prostate Cancer Therapeutics Drugs Market Size, 2019-2031
6.6 Asia
6.6.1 By Region - Asia Prostate Cancer Therapeutics Drugs Revenue, 2019-2031
6.6.2 By Region - Asia Prostate Cancer Therapeutics Drugs Sales, 2019-2031
6.6.3 China Prostate Cancer Therapeutics Drugs Market Size, 2019-2031
6.6.4 Japan Prostate Cancer Therapeutics Drugs Market Size, 2019-2031
6.6.5 South Korea Prostate Cancer Therapeutics Drugs Market Size, 2019-2031
6.6.6 Southeast Asia Prostate Cancer Therapeutics Drugs Market Size, 2019-2031
6.6.7 India Prostate Cancer Therapeutics Drugs Market Size, 2019-2031
6.7 South America
6.7.1 By Country - South America Prostate Cancer Therapeutics Drugs Revenue, 2019-2031
6.7.2 By Country - South America Prostate Cancer Therapeutics Drugs Sales, 2019-2031
6.7.3 Brazil Prostate Cancer Therapeutics Drugs Market Size, 2019-2031
6.7.4 Argentina Prostate Cancer Therapeutics Drugs Market Size, 2019-2031
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Prostate Cancer Therapeutics Drugs Revenue, 2019-2031
6.8.2 By Country - Middle East & Africa Prostate Cancer Therapeutics Drugs Sales, 2019-2031
6.8.3 Turkey Prostate Cancer Therapeutics Drugs Market Size, 2019-2031
6.8.4 Israel Prostate Cancer Therapeutics Drugs Market Size, 2019-2031
6.8.5 Saudi Arabia Prostate Cancer Therapeutics Drugs Market Size, 2019-2031
6.8.6 UAE Prostate Cancer Therapeutics Drugs Market Size, 2019-2031
7 Manufacturers & Brands Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Company Summary
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Prostate Cancer Therapeutics Drugs Major Product Offerings
7.1.4 Johnson & Johnson Prostate Cancer Therapeutics Drugs Sales and Revenue in Global (2019-2024)
7.1.5 Johnson & Johnson Key News & Latest Developments
7.2 Pfizer, Inc
7.2.1 Pfizer, Inc Company Summary
7.2.2 Pfizer, Inc Business Overview
7.2.3 Pfizer, Inc Prostate Cancer Therapeutics Drugs Major Product Offerings
7.2.4 Pfizer, Inc Prostate Cancer Therapeutics Drugs Sales and Revenue in Global (2019-2024)
7.2.5 Pfizer, Inc Key News & Latest Developments
7.3 AstraZeneca
7.3.1 AstraZeneca Company Summary
7.3.2 AstraZeneca Business Overview
7.3.3 AstraZeneca Prostate Cancer Therapeutics Drugs Major Product Offerings
7.3.4 AstraZeneca Prostate Cancer Therapeutics Drugs Sales and Revenue in Global (2019-2024)
7.3.5 AstraZeneca Key News & Latest Developments
7.4 Amgen, Inc
7.4.1 Amgen, Inc Company Summary
7.4.2 Amgen, Inc Business Overview
7.4.3 Amgen, Inc Prostate Cancer Therapeutics Drugs Major Product Offerings
7.4.4 Amgen, Inc Prostate Cancer Therapeutics Drugs Sales and Revenue in Global (2019-2024)
7.4.5 Amgen, Inc Key News & Latest Developments
7.5 AbbVie, Inc
7.5.1 AbbVie, Inc Company Summary
7.5.2 AbbVie, Inc Business Overview
7.5.3 AbbVie, Inc Prostate Cancer Therapeutics Drugs Major Product Offerings
7.5.4 AbbVie, Inc Prostate Cancer Therapeutics Drugs Sales and Revenue in Global (2019-2024)
7.5.5 AbbVie, Inc Key News & Latest Developments
7.6 Bayer AG
7.6.1 Bayer AG Company Summary
7.6.2 Bayer AG Business Overview
7.6.3 Bayer AG Prostate Cancer Therapeutics Drugs Major Product Offerings
7.6.4 Bayer AG Prostate Cancer Therapeutics Drugs Sales and Revenue in Global (2019-2024)
7.6.5 Bayer AG Key News & Latest Developments
7.7 Ipsen Group
7.7.1 Ipsen Group Company Summary
7.7.2 Ipsen Group Business Overview
7.7.3 Ipsen Group Prostate Cancer Therapeutics Drugs Major Product Offerings
7.7.4 Ipsen Group Prostate Cancer Therapeutics Drugs Sales and Revenue in Global (2019-2024)
7.7.5 Ipsen Group Key News & Latest Developments
7.8 Sanofi
7.8.1 Sanofi Company Summary
7.8.2 Sanofi Business Overview
7.8.3 Sanofi Prostate Cancer Therapeutics Drugs Major Product Offerings
7.8.4 Sanofi Prostate Cancer Therapeutics Drugs Sales and Revenue in Global (2019-2024)
7.8.5 Sanofi Key News & Latest Developments
7.9 Endo Pharmaceuticals
7.9.1 Endo Pharmaceuticals Company Summary
7.9.2 Endo Pharmaceuticals Business Overview
7.9.3 Endo Pharmaceuticals Prostate Cancer Therapeutics Drugs Major Product Offerings
7.9.4 Endo Pharmaceuticals Prostate Cancer Therapeutics Drugs Sales and Revenue in Global (2019-2024)
7.9.5 Endo Pharmaceuticals Key News & Latest Developments
7.10 Dendreon Corporation
7.10.1 Dendreon Corporation Company Summary
7.10.2 Dendreon Corporation Business Overview
7.10.3 Dendreon Corporation Prostate Cancer Therapeutics Drugs Major Product Offerings
7.10.4 Dendreon Corporation Prostate Cancer Therapeutics Drugs Sales and Revenue in Global (2019-2024)
7.10.5 Dendreon Corporation Key News & Latest Developments
8 Global Prostate Cancer Therapeutics Drugs Production Capacity, Analysis
8.1 Global Prostate Cancer Therapeutics Drugs Production Capacity, 2019-2031
8.2 Prostate Cancer Therapeutics Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Prostate Cancer Therapeutics Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Prostate Cancer Therapeutics Drugs Supply Chain Analysis
10.1 Prostate Cancer Therapeutics Drugs Industry Value Chain
10.2 Prostate Cancer Therapeutics Drugs Upstream Market
10.3 Prostate Cancer Therapeutics Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Prostate Cancer Therapeutics Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Prostate Cancer Therapeutics Drugs in Global Market
Table 2. Top Prostate Cancer Therapeutics Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Prostate Cancer Therapeutics Drugs Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Prostate Cancer Therapeutics Drugs Revenue Share by Companies, 2019-2024
Table 5. Global Prostate Cancer Therapeutics Drugs Sales by Companies, (K Pcs), 2019-2024
Table 6. Global Prostate Cancer Therapeutics Drugs Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Prostate Cancer Therapeutics Drugs Price (2019-2024) & (USD/Pcs)
Table 8. Global Manufacturers Prostate Cancer Therapeutics Drugs Product Type
Table 9. List of Global Tier 1 Prostate Cancer Therapeutics Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Prostate Cancer Therapeutics Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Prostate Cancer Therapeutics Drugs Revenue, (US$, Mn), 2022 & 2031
Table 12. By Type - Global Prostate Cancer Therapeutics Drugs Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Prostate Cancer Therapeutics Drugs Revenue (US$, Mn), 2024-2031
Table 14. By Type - Global Prostate Cancer Therapeutics Drugs Sales (K Pcs), 2019-2024
Table 15. By Type - Global Prostate Cancer Therapeutics Drugs Sales (K Pcs), 2024-2031
Table 16. By Sale Channel ? Global Prostate Cancer Therapeutics Drugs Revenue, (US$, Mn), 2022 & 2031
Table 17. By Sale Channel - Global Prostate Cancer Therapeutics Drugs Revenue (US$, Mn), 2019-2024
Table 18. By Sale Channel - Global Prostate Cancer Therapeutics Drugs Revenue (US$, Mn), 2024-2031
Table 19. By Sale Channel - Global Prostate Cancer Therapeutics Drugs Sales (K Pcs), 2019-2024
Table 20. By Sale Channel - Global Prostate Cancer Therapeutics Drugs Sales (K Pcs), 2024-2031
Table 21. By Region ? Global Prostate Cancer Therapeutics Drugs Revenue, (US$, Mn), 2022 VS 2031
Table 22. By Region - Global Prostate Cancer Therapeutics Drugs Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Prostate Cancer Therapeutics Drugs Revenue (US$, Mn), 2024-2031
Table 24. By Region - Global Prostate Cancer Therapeutics Drugs Sales (K Pcs), 2019-2024
Table 25. By Region - Global Prostate Cancer Therapeutics Drugs Sales (K Pcs), 2024-2031
Table 26. By Country - North America Prostate Cancer Therapeutics Drugs Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Prostate Cancer Therapeutics Drugs Revenue, (US$, Mn), 2024-2031
Table 28. By Country - North America Prostate Cancer Therapeutics Drugs Sales, (K Pcs), 2019-2024
Table 29. By Country - North America Prostate Cancer Therapeutics Drugs Sales, (K Pcs), 2024-2031
Table 30. By Country - Europe Prostate Cancer Therapeutics Drugs Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Prostate Cancer Therapeutics Drugs Revenue, (US$, Mn), 2024-2031
Table 32. By Country - Europe Prostate Cancer Therapeutics Drugs Sales, (K Pcs), 2019-2024
Table 33. By Country - Europe Prostate Cancer Therapeutics Drugs Sales, (K Pcs), 2024-2031
Table 34. By Region - Asia Prostate Cancer Therapeutics Drugs Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Prostate Cancer Therapeutics Drugs Revenue, (US$, Mn), 2024-2031
Table 36. By Region - Asia Prostate Cancer Therapeutics Drugs Sales, (K Pcs), 2019-2024
Table 37. By Region - Asia Prostate Cancer Therapeutics Drugs Sales, (K Pcs), 2024-2031
Table 38. By Country - South America Prostate Cancer Therapeutics Drugs Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Prostate Cancer Therapeutics Drugs Revenue, (US$, Mn), 2024-2031
Table 40. By Country - South America Prostate Cancer Therapeutics Drugs Sales, (K Pcs), 2019-2024
Table 41. By Country - South America Prostate Cancer Therapeutics Drugs Sales, (K Pcs), 2024-2031
Table 42. By Country - Middle East & Africa Prostate Cancer Therapeutics Drugs Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Prostate Cancer Therapeutics Drugs Revenue, (US$, Mn), 2024-2031
Table 44. By Country - Middle East & Africa Prostate Cancer Therapeutics Drugs Sales, (K Pcs), 2019-2024
Table 45. By Country - Middle East & Africa Prostate Cancer Therapeutics Drugs Sales, (K Pcs), 2024-2031
Table 46. Johnson & Johnson Company Summary
Table 47. Johnson & Johnson Prostate Cancer Therapeutics Drugs Product Offerings
Table 48. Johnson & Johnson Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 49. Johnson & Johnson Key News & Latest Developments
Table 50. Pfizer, Inc Company Summary
Table 51. Pfizer, Inc Prostate Cancer Therapeutics Drugs Product Offerings
Table 52. Pfizer, Inc Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 53. Pfizer, Inc Key News & Latest Developments
Table 54. AstraZeneca Company Summary
Table 55. AstraZeneca Prostate Cancer Therapeutics Drugs Product Offerings
Table 56. AstraZeneca Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 57. AstraZeneca Key News & Latest Developments
Table 58. Amgen, Inc Company Summary
Table 59. Amgen, Inc Prostate Cancer Therapeutics Drugs Product Offerings
Table 60. Amgen, Inc Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 61. Amgen, Inc Key News & Latest Developments
Table 62. AbbVie, Inc Company Summary
Table 63. AbbVie, Inc Prostate Cancer Therapeutics Drugs Product Offerings
Table 64. AbbVie, Inc Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 65. AbbVie, Inc Key News & Latest Developments
Table 66. Bayer AG Company Summary
Table 67. Bayer AG Prostate Cancer Therapeutics Drugs Product Offerings
Table 68. Bayer AG Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 69. Bayer AG Key News & Latest Developments
Table 70. Ipsen Group Company Summary
Table 71. Ipsen Group Prostate Cancer Therapeutics Drugs Product Offerings
Table 72. Ipsen Group Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 73. Ipsen Group Key News & Latest Developments
Table 74. Sanofi Company Summary
Table 75. Sanofi Prostate Cancer Therapeutics Drugs Product Offerings
Table 76. Sanofi Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 77. Sanofi Key News & Latest Developments
Table 78. Endo Pharmaceuticals Company Summary
Table 79. Endo Pharmaceuticals Prostate Cancer Therapeutics Drugs Product Offerings
Table 80. Endo Pharmaceuticals Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 81. Endo Pharmaceuticals Key News & Latest Developments
Table 82. Dendreon Corporation Company Summary
Table 83. Dendreon Corporation Prostate Cancer Therapeutics Drugs Product Offerings
Table 84. Dendreon Corporation Prostate Cancer Therapeutics Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2019-2024)
Table 85. Dendreon Corporation Key News & Latest Developments
Table 86. Prostate Cancer Therapeutics Drugs Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2021-2024 (K Pcs)
Table 87. Global Prostate Cancer Therapeutics Drugs Capacity Market Share of Key Manufacturers, 2021-2024
Table 88. Global Prostate Cancer Therapeutics Drugs Production by Region, 2019-2024 (K Pcs)
Table 89. Global Prostate Cancer Therapeutics Drugs Production by Region, 2024-2031 (K Pcs)
Table 90. Prostate Cancer Therapeutics Drugs Market Opportunities & Trends in Global Market
Table 91. Prostate Cancer Therapeutics Drugs Market Drivers in Global Market
Table 92. Prostate Cancer Therapeutics Drugs Market Restraints in Global Market
Table 93. Prostate Cancer Therapeutics Drugs Raw Materials
Table 94. Prostate Cancer Therapeutics Drugs Raw Materials Suppliers in Global Market
Table 95. Typical Prostate Cancer Therapeutics Drugs Downstream
Table 96. Prostate Cancer Therapeutics Drugs Downstream Clients in Global Market
Table 97. Prostate Cancer Therapeutics Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Prostate Cancer Therapeutics Drugs Segment by Type in 2022
Figure 2. Prostate Cancer Therapeutics Drugs Segment by Sale Channel in 2022
Figure 3. Global Prostate Cancer Therapeutics Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Prostate Cancer Therapeutics Drugs Market Size: 2022 VS 2031 (US$, Mn)
Figure 6. Global Prostate Cancer Therapeutics Drugs Revenue, 2019-2031 (US$, Mn)
Figure 7. Prostate Cancer Therapeutics Drugs Sales in Global Market: 2019-2031 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Prostate Cancer Therapeutics Drugs Revenue in 2022
Figure 9. By Type - Global Prostate Cancer Therapeutics Drugs Revenue, (US$, Mn), 2022 & 2031
Figure 10. By Type - Global Prostate Cancer Therapeutics Drugs Revenue Market Share, 2019-2031
Figure 11. By Type - Global Prostate Cancer Therapeutics Drugs Sales Market Share, 2019-2031
Figure 12. By Type - Global Prostate Cancer Therapeutics Drugs Price (USD/Pcs), 2019-2031
Figure 13. By Sale Channel - Global Prostate Cancer Therapeutics Drugs Revenue, (US$, Mn), 2022 & 2031
Figure 14. By Sale Channel - Global Prostate Cancer Therapeutics Drugs Revenue Market Share, 2019-2031
Figure 15. By Sale Channel - Global Prostate Cancer Therapeutics Drugs Sales Market Share, 2019-2031
Figure 16. By Sale Channel - Global Prostate Cancer Therapeutics Drugs Price (USD/Pcs), 2019-2031
Figure 17. By Region - Global Prostate Cancer Therapeutics Drugs Revenue, (US$, Mn), 2022 & 2031
Figure 18. By Region - Global Prostate Cancer Therapeutics Drugs Revenue Market Share, 2019 VS 2022 VS 2031
Figure 19. By Region - Global Prostate Cancer Therapeutics Drugs Revenue Market Share, 2019-2031
Figure 20. By Region - Global Prostate Cancer Therapeutics Drugs Sales Market Share, 2019-2031
Figure 21. By Country - North America Prostate Cancer Therapeutics Drugs Revenue Market Share, 2019-2031
Figure 22. By Country - North America Prostate Cancer Therapeutics Drugs Sales Market Share, 2019-2031
Figure 23. US Prostate Cancer Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 24. Canada Prostate Cancer Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 25. Mexico Prostate Cancer Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 26. By Country - Europe Prostate Cancer Therapeutics Drugs Revenue Market Share, 2019-2031
Figure 27. By Country - Europe Prostate Cancer Therapeutics Drugs Sales Market Share, 2019-2031
Figure 28. Germany Prostate Cancer Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 29. France Prostate Cancer Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 30. U.K. Prostate Cancer Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 31. Italy Prostate Cancer Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 32. Russia Prostate Cancer Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 33. Nordic Countries Prostate Cancer Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 34. Benelux Prostate Cancer Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 35. By Region - Asia Prostate Cancer Therapeutics Drugs Revenue Market Share, 2019-2031
Figure 36. By Region - Asia Prostate Cancer Therapeutics Drugs Sales Market Share, 2019-2031
Figure 37. China Prostate Cancer Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 38. Japan Prostate Cancer Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 39. South Korea Prostate Cancer Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 40. Southeast Asia Prostate Cancer Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 41. India Prostate Cancer Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 42. By Country - South America Prostate Cancer Therapeutics Drugs Revenue Market Share, 2019-2031
Figure 43. By Country - South America Prostate Cancer Therapeutics Drugs Sales Market Share, 2019-2031
Figure 44. Brazil Prostate Cancer Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 45. Argentina Prostate Cancer Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 46. By Country - Middle East & Africa Prostate Cancer Therapeutics Drugs Revenue Market Share, 2019-2031
Figure 47. By Country - Middle East & Africa Prostate Cancer Therapeutics Drugs Sales Market Share, 2019-2031
Figure 48. Turkey Prostate Cancer Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 49. Israel Prostate Cancer Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 50. Saudi Arabia Prostate Cancer Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 51. UAE Prostate Cancer Therapeutics Drugs Revenue, (US$, Mn), 2019-2031
Figure 52. Global Prostate Cancer Therapeutics Drugs Production Capacity (K Pcs), 2019-2031
Figure 53. The Percentage of Production Prostate Cancer Therapeutics Drugs by Region, 2022 VS 2031
Figure 54. Prostate Cancer Therapeutics Drugs Industry Value Chain
Figure 55. Marketing Channels
